pocketful logo light
pocketful logo light
Bharat Parenterals Ltd logo

Bharat Parenterals Ltd

NSE: BSE: 541096

₹1531.70

(0.65%)

Fri, 25 Sept 2026, 06:03 pm

Bharat Parenterals Share Price Live Chart

1 Day

(0.65%)

No Result Found

Summary

  • Market Cap (in Cr)

    927.14

  • Net Profit (in Cr)

    -43.68

  • P/B

    2.06

  • Sector P/E

    33.76

  • P/E

    0

  • EV/EBITDA

    56.08

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    -16.55

  • ROCE

    -4.76

  • Debt/Equity

    0.64

  • EPS (TTM)

    0

  • Dividend Yield

    0.07

  • Book Value

    467.55

  • Interest Cover

    -1.62

Analysis

all

thumbs up icon

Pros

  • Bharat Parenterals is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Bharat Parenterals is profitable, therefore cash runway is not a concern.
  • Bharat Parenterals is profitable, therefore cash runway is not a concern.
  • Debt is well covered by operating cash flow (1147.9%, greater than 20% of total debt).
  • Debt is covered by short term assets, assets are 74.3x debt.
thumbs up icon

Cons

  • Unable to evaluate Bharat Parenterals's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Bharat Parenterals's dividend against the top 25% market benchmark as the company has not reported any payouts.
  • High level of physical assets or inventory.
  • Bharat's remuneration is higher than average for companies of similar size in India.
  • Bharat Parenterals is not covered by any analysts.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters67.1767.1967.1967.1967.20
FII0.110.110.110.110.11
DII1.060.540.540.540.54
Public31.6632.1532.1532.1632.15
Government00000

Read More

Technical Analysis

RSI

76.92

MACD

51.25

50 DMA

1481.54

200 DMA

1261.58

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic2148.971804.971671.981460.971327.981116.97772.97
Fibonacci1804.971673.561592.371460.971329.561248.371116.97
Camarilla1633.601602.071570.531460.971507.471475.931444.40

Pivots Level: Classic

R3

+688.00

2148.97

R2

+344

1804.97

R1

+211.02

1671.98

1460.97
1460.97
Pivot Point
LTP: 1895.10

S1

-132.98

1327.98

S2

-344

1116.97

S3

-688

772.97

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    1603.95

  • 20-EMA

    1558.38

  • 30-EMA

    1530.29

  • 50-EMA

    1489.21

  • 100-EMA

    1413.60

  • 200-EMA

    1336.29

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
18 May 2026board-meetingsAccounts, Quarterly Results, Final Dividend
30 Jan 2026board-meetingsQuarterly Results
04 Sept 2025agm
19 Aug 2025dividendFinal Dividend - Rs. - 119 Sept 2025
12 May 2025dividend₹1.00 Dividend /Share19 Sept 2025
10 Jun 2024agm
25 May 2024dividendFinal Dividend - Rs. - 125 Jun 2024
22 May 2024dividend₹1.00 Dividend /Share25 Jun 2024
29 Apr 2024egm
01 Sept 2023agm

Read More

Peer Comparison

Bharat Parenterals Ltd logo

Bharat Parenterals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Read More

Bharat Parenterals Ltd About

Bharat Parenterals as a pharmaceutical company. The Company develops anti-retroviral drugs in the form of tablets, capsules, oral liquids, eye drops, lotion, creams, and injections for the treatment of various diseases. Bharat Parenterals serves clients in India.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1992

Headquarters

CEO

Bharat Kumar R Desai

Employees

Contact

Website icon

Website

http://www.bplindia.in

Email icon

Email

info@bplindia.in

Phone icon

Phone

91-2667-251679

Location icon

Location

Survey No 144 & 146 Haripura, Jarod Samlaya Road Tal Savli, Vadodara, Gujarat, 391520

Read More

Bharat Parenterals Ltd Company History

YearHistory
1992
  • Bhaarat Parenterals was incorporated on 3rd September under part IX of the Companies Act 1956.
  • The company obtained the certificate of Commencement of Business from the Registrar of Companies, Gujarat, Ahmedabad on 9th September.
2021
  • The company received the license and authorization from the Drugs Controller General of India and Central Drugs Standard Control Organisation for manufacturing and marketing Favipiravir Oral Suspension 100Mg/Ml.
2025
  • Bharat Parenterals completed the Paraguay Audit in April.
  • Bharat Parenterals received the Resilient Award from the Southern Gujarat Chamber of Commerce & Industry.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
SETU SECURITIES PRIVATE LIMITEDbulkBuy7527187828 Feb 2025
NEO APEX SHARE BROKING SERVICES LLPbulkSell7527187828 Feb 2025

Read More

Bharat Parenterals Ltd News

Bharat Parenterals to meet on Sept 29 for preferential issue

Bharat Parenterals Limited has scheduled a board meeting for September 29, 2026, to consider a preferential issue of equity shares. Trading window closes until 48 hours post-meeting.

24 Sept 2026

companies

Bharat Parenterals concludes 33rd AGM

Bharat Parenterals Limited concluded its 33rd AGM on September 19, 2026. Shareholders approved financials for FY26, declared a final dividend, and reappointed Executive Director Hemang Shah.

19 Sept 2026

companies

Bharat Parenterals listed on NSE from Aug 17

Bharat Parenterals Limited equity shares admitted to NSE trading on August 17, 2026. The company is now dual-listed on BSE and NSE under the Permitted to Trade category.

20 Aug 2026

ipo

Promoter acquires shares in Bharat Parenterals

Promoter Desai Shares and Stock Private Limited acquired 1,356 equity shares worth ₹18.06 lakh on BSE, increasing holding to 39.67%.

26 Jun 2026

companies

Desai Shares acquires 900 shares in Bharat Parenterals

Desai Shares and Stock Pvt Ltd acquired 900 shares, increasing its stake to 39.64% in Bharat Parenterals Limited via open market transactions.

16 Jun 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Bharat Parenterals Ltd?

    As of 25/09/2026 at 11:33 PM, Bharat Parenterals Ltd shares are trading at ₹1531.70.

  • 2.What is the market cap. of Bharat Parenterals Ltd?

    As of 25/09/2026, the market capitalization of Bharat Parenterals Ltd is ₹1,064.81 crore.

  • 3.When was Bharat Parenterals Ltd founded?

    Bharat Parenterals Ltd was founded in 1992.

  • 4.How can I buy shares of Bharat Parenterals Ltd?

    You can buy shares of Bharat Parenterals Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 5.What is the shareholding pattern of Bharat Parenterals Ltd?

    As of March,2026, promoters hold 67.17% in Bharat Parenterals Ltd, while FIIs, DIIs and public shareholders hold 0.11%, 1.06% and 31.66%, respectively.

  • 6.Does Bharat Parenterals Ltd pay dividends?

    Yes, Bharat Parenterals Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Final Dividend - Rs. - 1 per share.

  • 7.What is the dividend yield of Bharat Parenterals Ltd?

    As of 25 September, 2026, the dividend yield of Bharat Parenterals Ltd stands at 0.06%.

  • 8.What are the latest financial results of Bharat Parenterals Ltd?

    For January,2024, Bharat Parenterals Ltd reported revenue of ₹337.00 crore and a net profit of ₹-12.63 crore.

  • 9.Who is the CEO of Bharat Parenterals Ltd?

    The CEO of Bharat Parenterals Ltd is Bharat Kumar R Desai.